An intestinal epithelial defect conferring ER stress results in inflammation involving both innate and adaptive immunity

Mucosal Immunology

Volumn 4, Issue 3, 2011, Pages 354-364

  Eri, R D ^a,b   Adams, R J ^a   Tran, T V ^a   Tong, H ^a   Das, I ^a   Roche, D K ^a   Oancea, I ^a   Png, C W ^a   Jeffery, P L ^a   Radford Smith, G L ^c   Cook, M C ^d   Florin, T H ^a   McGuckin, M A ^a  

^a UNIVERSITY OF QUEENSLAND   (Australia)

^b UNIVERSITY OF TASMANIA   (Australia)

^c Royal Brisbane and Womens Hospital Research Foundation   (Australia)

^d Biology and Environment   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

CHEMOKINE RECEPTOR CCR6; GLYCOPROTEIN P 15095; INTERLEUKIN 12P40; INTERLEUKIN 12P70; INTERLEUKIN 17; INTERLEUKIN 17F; INTERLEUKIN 3; INTERLEUKIN 5; INTERLEUKIN 9; MESSENGER RNA; THYMIC STROMAL LYMPHOPOIETIN; TRANSFORMING GROWTH FACTOR BETA; TUMOR NECROSIS FACTOR ALPHA;

ADAPTIVE IMMUNITY; ADOPTIVE TRANSFER; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CD4+ T LYMPHOCYTE; CELL SECRETION; CONTROLLED STUDY; CYTOKINE PRODUCTION; DENDRITIC CELL; DISEASE SEVERITY; ENDOPLASMIC RETICULUM STRESS; ENTERITIS; GENE EXPRESSION; INNATE IMMUNITY; LAMINA PROPRIA; MOUSE; NONHUMAN; PRIORITY JOURNAL; REGULATORY T LYMPHOCYTE; T LYMPHOCYTE ACTIVATION;

EID: 79955106916     PISSN: 19330219     EISSN: None     Source Type: Journal    
DOI: 10.1038/mi.2010.74     Document Type: Article

References (45)

1. Fujino, S. et al. Increased expression of interleukin 17 in inflammatory bowel disease. Gut 52, 65-70 (2003). (Pubitemid 36020767)
2. Xavier, R.J. & Podolsky, D.K. Unravelling the pathogenesis of inflammatory bowel disease. Nature 448, 427-434 (2007). (Pubitemid 47123518)
3. Zaph, C. et al. Epithelial-cell-intrinsic IKK-beta expression regulates intestinal immune homeostasis. Nature 446, 552-556 (2007). (Pubitemid 46514719)
4. Nenci, A. et al. Epithelial NEMO links innate immunity to chronic intestinal inflammation. Nature 446, 557-561 (2007). (Pubitemid 46514732)
5. Rimoldi, M. et al. Intestinal immune homeostasis is regulated by the crosstalk between epithelial cells and dendritic cells. Nat. Immunol. 6, 507-514(2005). (Pubitemid 41716764)
6. Elson, C.O. et al. Monoclonal anti-interleukin 23 reverses active colitis in a T cell-mediated model in mice. Gastroenterology 132, 2359-2370 (2007). (Pubitemid 46890867)
7. Uhlig, H.H. et al. Differential activity of IL-12 and IL-23 in mucosal and systemic innate immune pathology. Immunity 25, 309-318 (2006).
8. Kobayashi, T. et al. IL-23 differentially regulates the Th1/Th17 balance in ulcerative colitis and Crohn's disease. Gut 57, 1682-1689 (2008).
9. Rovedatti, L. et al. Differential regulation of interleukin-17 and interferon-\{gamma\} production in inflammatory bowel disease. Gut 58, 1629-1636(2009).
10. Duerr, R.H. et al. A genome-wide association study identifies IL23R as an inflammatory bowel disease gene. Science 314, 1461-1463 (2006). (Pubitemid 44871953)
11. Barrett, J.C. et al. Genome-wide association defines more than 30 distinct susceptibility loci for Crohn's disease. Nat. Genet. 40, 955-962 (2008).
12. Heazlewood, C.K. et al. Aberrant mucin assembly in mice causes endoplasmic reticulum stress and spontaneous inflammation resembling ulcerative colitis. PLoS Med. 5, e54 (2008).
13. Mahida, Y.R., Wu, K. & Jewell, D.P. Enhanced production of interleukin 1 -beta by mononuclear cells isolated from mucosa with active ulcerative colitis of Crohn's disease. Gut 30, 835-838 (1989). (Pubitemid 19167787)
14. Gionchetti, P. et al. Interleukin 1 beta (IL-1 beta) release from fresh and cultured colonic mucosa in patients with ulcerative colitis (UC). Agents Actions Spec No, C50-C52 (1992).
15. Olson, A.D., Ayass, M. & Chensue, S. Tumor necrosis factor and IL-1 beta expression in pediatric patients with inflammatory bowel disease. J. Pediatr. Gastroenterol. Nutr. 16, 241-246 (1993). (Pubitemid 23127643)
16. Fuss, I. J. et al. Disparate CD4+lamina propria (LP) lymphokine secretion profiles in inflammatory bowel disease. Crohn's disease LP cells manifest increased secretion of IFN-gamma, whereas ulcerative colitis LP cells manifest increased secretion of IL-5. J. Immunol. 157, 1261-1270 (1996). (Pubitemid 126449643)
17. Reimund, J.M. et al. Mucosal inflammatory cytokine production by intestinal biopsies in patients with ulcerative colitis and Crohn's disease. J. Clin. Immunol 16, 144-150 (1996).
18. Vainer, B., Nielsen, O.H., Hendel, J., Horn, T. & Kirman, I. Colonic expression and synthesis of interleukin 13 and interleukin 15 in inflammatory bowel disease. Cytokine 12, 1531-1536 (2000).
19. Fuss, I.J. et al. Nonclassical CD1d-restricted NKT cells that produce IL-13 characterize an atypical Th2 response in ulcerative colitis. J. Clin. Invest. 113, 1490-1497 (2004). (Pubitemid 39071705)
20. Kadivar, K. et al. Intestinal interleukin-13 in pediatric inflammatory bowel disease patients. Inflamm. Bowel. Dis. 10, 593-598 (2004). (Pubitemid 39276467)
21. Heller, F. et al. Interleukin-13 is the key effector Th2 cytokine in ulcerative colitis that affects epithelial tight junctions, apoptosis, and cell restitution. Gastroenterology 129, 550-564 (2005). (Pubitemid 41096643)
22. Nenci, A. et al. Epithelial NEMO links innate immunity to chronic intestinal inflammation. Nature 446, 557-561 (2007). (Pubitemid 46514732)
23. VanderSluis, M. et al. Muc2-deficient mice spontaneously develop colitis, indicating that MUC2 is critical for colonic protection. Gastroenterology 131, 117-129 (2006). (Pubitemid 44015753)
24. Park, S.W. et al. The protein disulfide isomerase AGR2 is essential for production of intestinal mucus. Proc. Natl. Acad. Sci. USA 106, 6950-6955 (2009).
25. Kaser, A. et al. XBP1 links ER stress to intestinal inflammation and confers genetic risk for human inflammatory bowel disease. Cell 134, 743-756 (2008).
26. Brandl, K. et al. Enhanced sensitivity to DSS colitis caused by a hypomorphic Mbtpsl mutation disrupting the ATF6-driven unfolded protein response. Proc. Natl. Acad. Sci. USA 106, 3300-3305 (2009).
27. Cadwell, K. et al. A key role for autophagy and the autophagy gene Atg1611 in mouse and human intestinal Paneth cells. Nature 456, 259-263 (2008).
28. Bernales, S., McDonald, K.L. & Walter, P. Autophagy counterbalances endoplasmic reticulum expansion during the unfolded protein response. PLoS Biol. 4, e423 (2006).
29. McGovern, D.P. et al. Genome-wide association identifies multiple ulcerative colitis susceptibility loci. Nat. Genet 42, 332-337 (2010).
30. Yen, D. et al. IL-23 is essential for T cell-mediated colitis and promotes inflammation via IL-17 and IL-6. J. Clin. Invest. 116, 1310-1316 (2006).
31. Ito, R. et al. Involvement of IL-17A in the pathogenesis of DSS-induced colitis in mice. Biochem. Biophys. Res. Commun. 377, 12-16 (2008).
32. O'Connor, W. Jr., Zenewicz, L.A. & Flavell, R.A. The dual nature of T(H)17 cells: shifting the focus to function. Nat. Immunol. 11, 471-476 (2010).
33. Leppkes, M. et al. RORgamma-expressing Th17 cells induce murine chronic intestinal inflammation via redundant effects of IL-17A and IL-17F Gastroenterology 136, 257-267 (2009).
34. Fina, D. et al. Regulation of gut inflammation and th17 cell response by interleukin-21. Gastroenterology 134, 1038-1048 (2008).
35. O'Connor, W. Jr. et al. A protective function for interleukin 17A in T cell-mediated intestinal inflammation. Nat. Immunol. 10, 603-609 (2009).
36. Ogawa, A., Andoh, A., Araki, Y., Bamba, T. & Fujiyama, Y. Neutralization of interleukin-17 aggravates dextran sulfate sodium-induced colitis in mice. Clin. Immunol. 110, 55-62 (2004). (Pubitemid 38177420)
37. Izcue, A. et al. Interleukin-23 restrains regulatory T cell activity to drive T cell-dependent colitis. Immunity 28, 559-570 (2008). (Pubitemid 351467043)
38. Yu, Q.T. et al. Expression and functional characterization of FOXP3+ CD4+ regulatory T cells in ulcerative colitis. Inflamm. Bowel. Dis. 13, 191-199(2007). (Pubitemid 46806228)
39. Murai, M. et al. Interleukin 10 acts on regulatory T cells to maintain expression of the transcription factor Foxp3 and suppressive function in mice with colitis. Nat. Immunol. 10, 1178-1184 (2009).
40. Johansson, M.E. et al. The inner of the two Muc2 mucin-dependent mucus layers in colon is devoid of bacteria. Proc. Natl. Acad. Sci. USA 105, 15064-15069(2008).
41. Taylor, B.C. et al. TSLP regulates intestinal immunity and inflammation in mouse models of helminth infection and colitis. J. Exp. Med. 206, 655-667 (2009).
42. Izcue, A., Coombes, J.L. & Powrie, F. Regulatory lymphocytes and intestinal inflammation. Annu. Rev. Immunol. 27, 313-338 (2009).
43. Weigmann, B. et al. Isolation and subsequent analysis of murine lamina propria mononuclear cells from colonic tissue. Nat. Protoc. 2, 2307-2311 (2007).
44. Pfaffl, M.W. A new mathematical model for relative quantification in realtime RT-PCR. Nucleic Acids Res. 29, e45 (2001).
45. Ostanin, D.V. et al. T cell transfer model of chronic colitis: concepts, considerations, and tricks of the trade. Am. J. Physiol. Gastrointest. Liver Physiol. 296, G135-3146 (2009).